XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.
L
L

LaboratoryCorporation


뉴스

NOWDiagnostics And Labcorp Collaborate To Expand Access To The Only Marketing Authorized Over-The-Counter Syphilis Test In The U.S.

BRIEF-NOWDiagnostics And Labcorp Collaborate To Expand Access To The Only FDA-Marketing Authorized Over-The-Counter Syphilis Test In The U.S. Oct 16 (Reuters) - Labcorp Holdings Inc LH.N : NOWDIAGNOSTICS AND LABCORP COLLABORATE TO EXPAND ACCESS TO THE ONLY FDA-MARKETING AUTHORIZED OVER-THE-COUNTER SYPHILIS TEST IN THE U.S. Source text for Eikon: ID
L

Labcorp Expands Sexually Transmitted Infection Test Offerings With Rapid Syphilis Test

BRIEF-Labcorp Expands Sexually Transmitted Infection Test Offerings With Rapid Syphilis Test Oct 10 (Reuters) - Labcorp Holdings Inc LH.N : LABCORP EXPANDS SEXUALLY TRANSMITTED INFECTION (STI) TEST OFFERINGS WITH RAPID SYPHILIS TEST LABCORP: PLANS TO MAKE TEST AVAILABLE TO PROVIDERS BY END OF 2024 AND DIRECTLY TO PATIENTS THROUGH LABCORP ONDEMAND I
L

WHO approves first mpox diagnostic test for emergency use

UPDATE 4-WHO approves first mpox diagnostic test for emergency use Updates Oct. 3 story to add company statement in paragraph 4 Oct 3 (Reuters) - The World Health Organization authorized Abbott Laboratories' ABT.N mpox diagnostic test for emergency use on Thursday, the first such approval in the agency's effort to bolster testing capabilities in countries facing outbreaks of the disease.
A
R
L

U.S. Amerant Bancorp, BlackRock, Equinix

U.S. RESEARCH ROUNDUP-Amerant Bancorp, BlackRock, Equinix Oct 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amerant Bancorp, BlackRock and Equinix, on Tuesday. HIGHLIGHTS * Amerant Bancorp Inc AMTB.N : Stephens raises to overweight from equal-weight * BlackRock BLK.N : JP Morgan raises target price to $864 from $774 * Equinix Inc EQIX.O : JP Morgan raises target price to $975 from $950 * Interpublic Group of Comp
A
P
C
L
R

U.S. STOCKS IonQ, Cassava Sciences, MeridianLink

BUZZ-U.S. STOCKS ON THE MOVE-IonQ, Cassava Sciences, MeridianLink Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The blue-chip Dow rose on Friday to hit an intraday record and small-cap stocks outperformed after a benign inflation report cleared the way for the Federal Reserve to focus on shoring up the labor market while continuing its interest rate easing.
C
E
R
S
R
W
U
U
G
C
L

U.S. STOCKS Regeneron, HP Inc, Honeywell International

BUZZ-U.S. STOCKS ON THE MOVE-Regeneron, HP Inc, Honeywell International Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The blue-chip Dow rose on Friday to hit an intraday record high and small-cap stocks outperformed after a benign inflation report cleared the way for the Federal Reserve to focus on shoring up the labor market while continuing its interest rate easing.
A
C
E
L
R
S
W
W
U
U
D
C
L

Delay in reimbursement cut to ease pressure on U.S. lab operators, analysts say

BUZZ-Delay in reimbursement cut to ease pressure on U.S. lab operators, analysts say ** Delay in cuts to reimbursement rates for some lab tests under Medicare to aid 2025 rev and earnings of U.S. lab owners such as Labcorp LH.N and Quest Diagnostics DGX.N , analysts say ** LH shares rise 1.1% to $222.73, DGX shares up nearly 1% to $155.51 ** U.S. Congress on Wednesday deferred cuts to reimbursement rates from 2025 to 2026 ** "The delay was in-line with expectations as both LH and DGX have previo
L

U.S. Cardinal Health, Factset, Paylocity

U.S. RESEARCH ROUNDUP-Cardinal Health, Factset, Paylocity Sept 23 (Reuters) - .Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cardinal Health, Factset and Paylocity Holding on Monday. HIGHLIGHTS * Cardinal Health Inc CAH.N : Baird raises target price to $140 from $137 * Factset FDS.N : Jefferies raises target price to $486 from $435 * Marinus Pharmaceuticals Inc MRNS.O : Oppenheimer raises to outperform from perform * Paylocity
B
P
V
A
P
C
D
L
L
U

U.S. Factset, FedEx, Thermo Fisher Scientific

U.S. RESEARCH ROUNDUP-Factset, FedEx, Thermo Fisher Scientific Sept 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Factset, FedEx and Thermo Fisher Scientific on Friday. HIGHLIGHTS * Arthur J. Gallagher & Co. AJG.N : RBC raises target price to $320 from $310 * Factset FDS.N : RBC raises target price to $503 from $464 * FedEx Corp FDX.N : Baird cuts target price to $320 from $340 * IQVIA Holdings Inc IQV.N : Baird
A
A
A
B
D
E
N
X
T
A
D
I
L
P

Cinven To Sell Minority Stake In SYNLAB To Labcorp

BRIEF-Cinven To Sell Minority Stake In SYNLAB To Labcorp Sept 17 (Reuters) - Cinven: CINVEN: TO SELL MINORITY STAKE IN SYNLAB TO LABCORP CINVEN: PURCHASE PRICE FOR INDIRECT MINORITY STAKE OF 15% WAS ABOUT EUR 140 MILLION Further company coverage: LH.N
L

Labcorp Completes Acquisition Of Select Assets Of Bioreference Health's Diagnostics Business From Opko Health

BRIEF-Labcorp Completes Acquisition Of Select Assets Of Bioreference Health's Diagnostics Business From Opko Health Sept 16 (Reuters) - Labcorp Holdings Inc LH.N : LABCORP COMPLETES ACQUISITION OF SELECT ASSETS OF BIOREFERENCE HEALTH'S DIAGNOSTICS BUSINESS FROM OPKO HEALTH Source text for Eikon: ID:nPnbrzkBja Further company coverage: LH.N
O
L

U.S. Constellation Energy, Eli Lilly, Talen Energy

U.S. RESEARCH ROUNDUP-Constellation Energy, Eli Lilly, Talen Energy Sept 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Constellation Energy, Eli Lilly and Talen Energy, on Friday. HIGHLIGHTS * Constellation Energy Corp CEG.O : Jefferies initiates with hold rating; target $183 * Eli Lilly LLY.N : JP Morgan raises target price to $1,100 from $1,050 * Moderna MRNA.O : JP Morgan cuts to underweight from neutral * Vo
A
C
C
F
F
H
H
H
I
K
W
F
D
T
Z
A
A
D
E
H
L

Origin of human bird flu case in Missouri still unknown, U.S. CDC says

UPDATE 1-Origin of human bird flu case in Missouri still unknown, U.S. CDC says Adds context in paragraphs 7-12, bylines By Leah Douglas and Julie Steenhuysen WASHINGTON, Sept 12 (Reuters) - Epidemiologists have not yet identified exactly how a person in Missouri contracted bird flu last week, said the U.S. Centers for Disease Control and Prevention on Thursday.
L

Origin of human bird flu case in Missouri still unknown, U.S. CDC says

RPT-Origin of human bird flu case in Missouri still unknown, U.S. CDC says Repeats URGENT to attach to snaps WASHINGTON, Sept 12 (Reuters) - Epidemiologists have not yet identified exactly how a person in Missouri contracted bird flu last week, said the U.S. Centers for Disease Control and Prevention on Thursday. The human case was the 14th diagnosed in the U.S.
L

U.S. Coca-Cola, KB Home, Newmark Group

U.S. RESEARCH ROUNDUP-Coca-Cola, KB Home, Newmark Group Sept 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Coca-Cola, KB Home and Newmark Group on Thursday. HIGHLIGHTS * Capital Clean Energy Carriers CCEC.O : Evercore ISI initiates coverage with outperform rating * Coca-Cola Co KO.N : CFRA cuts to hold from buy * KB Home KBH.N : RBC cuts to underperform from sector perform * Newmark Group Inc NMRK.O : KBW raises
B
U
C
D
C
C
L

WHO invites makers of mpox tests for emergency review in push for rapid access

UPDATE 2-WHO invites makers of mpox tests for emergency review in push for rapid access Adds details and background throughout Aug 29 (Reuters) - The World Health Organization on Thursday s ought to speed up the access to diagnostic tests for mpox by asking manufacturers to submit their products for an emergency review. The agency has been in discussions with manufacturers about the need for effective diagnostics, particularly in low-income g roups .
L

Diagnostics firm Labcorp weighs ramping up mpox testing capacity

UPDATE 2-Diagnostics firm Labcorp weighs ramping up mpox testing capacity Adds details on other tests from paragraph 6 By Sneha S K Aug 26 (Reuters) - Diagnostics firm Labcorp LH.N said it is working with U.S. health regulators to determine if it needed to ramp up its mpox testing capacity, as countries outside Africa detect a new type of the virus for the first time.
A
L

Labcorp Says It Has Capacity To Process About 25,000 Mpox Tests Per Month

BRIEF-Labcorp Says It Has Capacity To Process About 25,000 Mpox Tests Per Month Aug 26 (Reuters) - Labcorp Holdings Inc LH.N : LABCORP SAYS IT IS WORKING CLOSELY WITH US CDC AND PUBLIC HEALTH AGENCIES TO MONITOR MPOX OUTBREAK AND WEIGH NEED FOR INCREASED SUPPLIES OR TESTING LABCORP SAYS CURRENTLY PROCESSING ABOUT 500 MPOX TESTS A MONTH, BUT HAVE CA
L

Labcorp Says, Co, Units, Entered Into A Three-Year $300 Mln Accounts Receivable Securitization Facility

BRIEF-Labcorp Says, Co, Units, Entered Into A Three-Year $300 Mln Accounts Receivable Securitization Facility Aug 23 (Reuters) - Labcorp Holdings Inc LH.N : LABCORP - CO, UNITS, ENTERED INTO A THREE-YEAR $300 MILLION ACCOUNTS RECEIVABLE SECURITIZATION FACILITY LABCORP - SECURITIZATION FACILITY CONTAINS ACCORDION TO INCREASE FACILITY LIMIT UP TO $70
L

PreciseDx Secures $20.7 Million Series B to Advance Powered Cancer Risk Assessments

BRIEF-PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments Aug 21 (Reuters) - Quest Diagnostics Inc DGX.N : PRECISEDX: RAISED $20.7 MILLION IN SERIES B FUNDING, BRINGING TOTAL FUNDING TO DATE TO $31.5 MILLION PRECISEDX: ADDITIONAL PARTICIPANTS IN ROUND INCLUDE LABCORP, QUEST DIAGNOSTICS, GENHENN CAPITAL VENTURE Sou
L



조건

인기 자산

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.